Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting ...

A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Eisai (ESAIY) and Biogen (BIIB) announced that a positive opinion has been received from the Committee for Medicinal Products for Human Use of ...

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...

The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and ...

Highlights: Notice of positive opinion received from the European Medicines Agency for Orphan Medicinal Product Designation for NUZ-001 in Amyotrophic Lateral Sclerosis Orphan Designation offers 10 ...

September 2024: authorization received from The European Medicines Agency to initiate the INVINCIBLE-3 Study in Europe. September 2024: authorization from the Swiss Medic and the Swiss Ethics ...

As the US presidential election result became clear, European leaders followed a similar formula when congratulating President-elect Trump. They offered their congratulations, mentioned previous good ...

US President-elect Donald Trump, who has repeatedly boasted that he could end the Russia-Ukraine war in his first 24 hours in power, is likely to call on European soldiers to enforce an 800-mile ...

In the past decade, CPP has achieved significant success, including seven regulatory milestones, including the first ...